Activatiqn of histone deacetylase 1 (HDAC1) protects against DNA damage and increases neuronal survival

Details for Australian Patent Application No. 2009274571 (hide)

Owner The General Hospital Corporation Massachusetts Institute of Technology

Inventors Tsai, Li-Huei; Haggarty, Stephen; Kim, Dohoon

Agent Pizzeys

Pub. Number AU-A-2009274571

PCT Pub. Number WO2010/011318

Priority 61/135,716 23.07.08 US

Filing date 23 July 2009

Wipo publication date 28 January 2010

International Classifications

C07C 259/04 (2006.01) Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

Event Publications

17 March 2011 Amendment Made

  The nature of the amendment is: Amend the invention title to read Activation of histone deacetylase 1 (HDAC1) protects against DNA damage and increases neuronal survival

17 March 2011 PCT application entered the National Phase

  PCT publication WO2010/011318 Priority application(s): WO2010/011318

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009274584-Compositions and methods related to SIRT1 function

2009274569-Substituted 1,2,3,4tetrahydrocyclopenta[b]indol-3-yl) acetic acid derivatives useful in the treatment of autoimmune and inflammatory disorders